aluates Reports

$ 0.0

Automative

HPV Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: March 2024

Report Code: QYRE-Auto-20Q2432

Global HPV Testing Market Size Status and Forecast 2021 2027

BUY CHAPTERS

HPV Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-20Q2432

Report

March 2024

Pages:89

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Hologic Inc

Abbott Laboratories

Seegene

Qiagen

Qiagen NV

Roche Diagnostics

HPV Testing - Market Size

The global market for HPV Testing was estimated to be worth US$ 802 million in 2023 and is forecast to a readjusted size of US$ 1410.6 million by 2030 with a CAGR of 8.3% during the forecast period 2024-2030

HPV Testing - Market

The human papillomavirus (HPV) test detects the presence of human papillomavirus, a virus that can lead to the development of genital warts, abnormal cervical cells or cervical cancer. The HPV testing is further classified into three sub-segments, namely, follow-up testing, co-testing, HPV primary testing.

Global HPV Testing key players include Qiagen, Roche Diagnostics, Hologic, Abbott Laboratories, BD, etc. Global top five players hold a share about 80%.

North America is the largest market, with a share about 50%, followed by Europe and Asia-Pacific, having a total share about 45 percent.

In terms of product, Co-testing is the largest segment, with a share about 55%. And in terms of application, the largest application is Cervical Cancer Screening, followed by Vaginal Cancer Screening, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for HPV Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of HPV Testing by region & country, by Type, and by Application.

The HPV Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HPV Testing.

Market Segmentation

Scope of HPV Testing - Market Report

Report Metric	Details
Report Name	HPV Testing - Market
Forecasted market size in 2030	US$ 1410.6 million
CAGR	8.3%
Forecasted years	2024 - 2030
Segment by Type:	HPV Testing Follow-up HPV Testing Co-testing
Segment by Application	Cervical Cancer Screening Vaginal Cancer Screening Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Qiagen, Roche Diagnostics, Hologic, Abbott Laboratories, BD, Seegene, Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of HPV Testing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of HPV Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of HPV Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the HPV Testing - Market size in 2030?

Ans: The HPV Testing - Market size in 2030 will be US$ 1410.6 million.

What is the market share of major companies in HPV Testing - Market?

Ans: Global top five players hold a share about 80%.

What is the HPV Testing - Market share by type?

Ans: In terms of product, Co-testing is the largest segment, with a share about 55%.

Who are the main players in the HPV Testing - Market report?

Ans: The main players in the HPV Testing - Market are Qiagen, Roche Diagnostics, Hologic, Abbott Laboratories, BD, Seegene, Inc.

What are the Application segmentation covered in the HPV Testing - Market report?

Ans: The Applications covered in the HPV Testing - Market report are Cervical Cancer Screening, Vaginal Cancer Screening, Other

What are the Type segmentation covered in the HPV Testing - Market report?

Ans: The Types covered in the HPV Testing - Market report are HPV Testing, Follow-up HPV Testing, Co-testing

1 Market Overview

1.1 HPV Testing Product Introduction

1.2 Global HPV Testing Market Size Forecast

1.3 HPV Testing Market Trends & Drivers

1.3.1 HPV Testing Industry Trends

1.3.2 HPV Testing Market Drivers & Opportunity

1.3.3 HPV Testing Market Challenges

1.3.4 HPV Testing Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global HPV Testing Players Revenue Ranking (2023)

2.2 Global HPV Testing Revenue by Company (2019-2024)

2.3 Key Companies HPV Testing Manufacturing Base Distribution and Headquarters

2.4 Key Companies HPV Testing Product Offered

2.5 Key Companies Time to Begin Mass Production of HPV Testing

2.6 HPV Testing Market Competitive Analysis

2.6.1 HPV Testing Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by HPV Testing Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HPV Testing as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 HPV Testing

3.1.2 Follow-up HPV Testing

3.1.3 Co-testing

3.2 Global HPV Testing Sales Value by Type

3.2.1 Global HPV Testing Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global HPV Testing Sales Value, by Type (2019-2030)

3.2.3 Global HPV Testing Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Cervical Cancer Screening

4.1.2 Vaginal Cancer Screening

4.1.3 Other

4.2 Global HPV Testing Sales Value by Application

4.2.1 Global HPV Testing Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global HPV Testing Sales Value, by Application (2019-2030)

4.2.3 Global HPV Testing Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global HPV Testing Sales Value by Region

5.1.1 Global HPV Testing Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global HPV Testing Sales Value by Region (2019-2024)

5.1.3 Global HPV Testing Sales Value by Region (2025-2030)

5.1.4 Global HPV Testing Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America HPV Testing Sales Value, 2019-2030

5.2.2 North America HPV Testing Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe HPV Testing Sales Value, 2019-2030

5.3.2 Europe HPV Testing Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific HPV Testing Sales Value, 2019-2030

5.4.2 Asia Pacific HPV Testing Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America HPV Testing Sales Value, 2019-2030

5.5.2 South America HPV Testing Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa HPV Testing Sales Value, 2019-2030

5.6.2 Middle East & Africa HPV Testing Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions HPV Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions HPV Testing Sales Value

6.3 United States

6.3.1 United States HPV Testing Sales Value, 2019-2030

6.3.2 United States HPV Testing Sales Value by Type (%), 2023 VS 2030

6.3.3 United States HPV Testing Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe HPV Testing Sales Value, 2019-2030

6.4.2 Europe HPV Testing Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe HPV Testing Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China HPV Testing Sales Value, 2019-2030

6.5.2 China HPV Testing Sales Value by Type (%), 2023 VS 2030

6.5.3 China HPV Testing Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan HPV Testing Sales Value, 2019-2030

6.6.2 Japan HPV Testing Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan HPV Testing Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea HPV Testing Sales Value, 2019-2030

6.7.2 South Korea HPV Testing Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea HPV Testing Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia HPV Testing Sales Value, 2019-2030

6.8.2 Southeast Asia HPV Testing Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia HPV Testing Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India HPV Testing Sales Value, 2019-2030

6.9.2 India HPV Testing Sales Value by Type (%), 2023 VS 2030

6.9.3 India HPV Testing Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Qiagen

7.1.1 Qiagen Profile

7.1.2 Qiagen Main Business

7.1.3 Qiagen HPV Testing Products, Services and Solutions

7.1.4 Qiagen HPV Testing Revenue (US$ Million) & (2019-2024)

7.1.5 Qiagen Recent Developments

7.2 Roche Diagnostics

7.2.1 Roche Diagnostics Profile

7.2.2 Roche Diagnostics Main Business

7.2.3 Roche Diagnostics HPV Testing Products, Services and Solutions

7.2.4 Roche Diagnostics HPV Testing Revenue (US$ Million) & (2019-2024)

7.2.5 Roche Diagnostics Recent Developments

7.3 Hologic

7.3.1 Hologic Profile

7.3.2 Hologic Main Business

7.3.3 Hologic HPV Testing Products, Services and Solutions

7.3.4 Hologic HPV Testing Revenue (US$ Million) & (2019-2024)

7.3.5 Abbott Laboratories Recent Developments

7.4 Abbott Laboratories

7.4.1 Abbott Laboratories Profile

7.4.2 Abbott Laboratories Main Business

7.4.3 Abbott Laboratories HPV Testing Products, Services and Solutions

7.4.4 Abbott Laboratories HPV Testing Revenue (US$ Million) & (2019-2024)

7.4.5 Abbott Laboratories Recent Developments

7.5 BD

7.5.1 BD Profile

7.5.2 BD Main Business

7.5.3 BD HPV Testing Products, Services and Solutions

7.5.4 BD HPV Testing Revenue (US$ Million) & (2019-2024)

7.5.5 BD Recent Developments

7.6 Seegene, Inc.

7.6.1 Seegene, Inc. Profile

7.6.2 Seegene, Inc. Main Business

7.6.3 Seegene, Inc. HPV Testing Products, Services and Solutions

7.6.4 Seegene, Inc. HPV Testing Revenue (US$ Million) & (2019-2024)

7.6.5 Seegene, Inc. Recent Developments

8 Industry Chain Analysis

8.1 HPV Testing Industrial Chain

8.2 HPV Testing Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 HPV Testing Sales Model

8.5.2 Sales Channel

8.5.3 HPV Testing Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Hologic Inc

Abbott Laboratories

Seegene

Qiagen

Qiagen NV

Roche Diagnostics

List of Tables

Table 1. HPV Testing Market Trends

Table 2. HPV Testing Market Drivers & Opportunity

Table 3. HPV Testing Market Challenges

Table 4. HPV Testing Market Restraints

Table 5. Global HPV Testing Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global HPV Testing Revenue Market Share by Company (2019-2024)

Table 7. Key Companies HPV Testing Manufacturing Base Distribution and Headquarters

Table 8. Key Companies HPV Testing Product Type

Table 9. Key Companies Time to Begin Mass Production of HPV Testing

Table 10. Global HPV Testing Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HPV Testing as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global HPV Testing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global HPV Testing Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global HPV Testing Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global HPV Testing Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global HPV Testing Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global HPV Testing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global HPV Testing Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global HPV Testing Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global HPV Testing Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global HPV Testing Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global HPV Testing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global HPV Testing Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global HPV Testing Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global HPV Testing Sales Value by Region (2019-2024) & (%)

Table 27. Global HPV Testing Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions HPV Testing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions HPV Testing Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions HPV Testing Sales Value, (2025-2030) & (US$ Million)

Table 31. Qiagen Basic Information List

Table 32. Qiagen Description and Business Overview

Table 33. Qiagen HPV Testing Products, Services and Solutions

Table 34. Revenue (US$ Million) in HPV Testing Business of Qiagen (2019-2024)

Table 35. Qiagen Recent Developments

Table 36. Roche Diagnostics Basic Information List

Table 37. Roche Diagnostics Description and Business Overview

Table 38. Roche Diagnostics HPV Testing Products, Services and Solutions

Table 39. Revenue (US$ Million) in HPV Testing Business of Roche Diagnostics (2019-2024)

Table 40. Roche Diagnostics Recent Developments

Table 41. Hologic Basic Information List

Table 42. Hologic Description and Business Overview

Table 43. Hologic HPV Testing Products, Services and Solutions

Table 44. Revenue (US$ Million) in HPV Testing Business of Hologic (2019-2024)

Table 45. Hologic Recent Developments

Table 46. Abbott Laboratories Basic Information List

Table 47. Abbott Laboratories Description and Business Overview

Table 48. Abbott Laboratories HPV Testing Products, Services and Solutions

Table 49. Revenue (US$ Million) in HPV Testing Business of Abbott Laboratories (2019-2024)

Table 50. Abbott Laboratories Recent Developments

Table 51. BD Basic Information List

Table 52. BD Description and Business Overview

Table 53. BD HPV Testing Products, Services and Solutions

Table 54. Revenue (US$ Million) in HPV Testing Business of BD (2019-2024)

Table 55. BD Recent Developments

Table 56. Seegene, Inc. Basic Information List

Table 57. Seegene, Inc. Description and Business Overview

Table 58. Seegene, Inc. HPV Testing Products, Services and Solutions

Table 59. Revenue (US$ Million) in HPV Testing Business of Seegene, Inc. (2019-2024)

Table 60. Seegene, Inc. Recent Developments

Table 61. Key Raw Materials Lists

Table 62. Raw Materials Key Suppliers Lists

Table 63. HPV Testing Downstream Customers

Table 64. HPV Testing Distributors List

Table 65. Research Programs/Design for This Report

Table 66. Key Data Information from Secondary Sources

Table 67. Key Data Information from Primary Sources

Table 68. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. HPV Testing Product Picture

Figure 2. Global HPV Testing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global HPV Testing Sales Value (2019-2030) & (US$ Million)

Figure 4. HPV Testing Report Years Considered

Figure 5. Global HPV Testing Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by HPV Testing Revenue in 2023

Figure 7. HPV Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. HPV Testing Picture

Figure 9. Follow-up HPV Testing Picture

Figure 10. Co-testing Picture

Figure 11. Global HPV Testing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 12. Global HPV Testing Sales Value Market Share by Type, 2023 & 2030

Figure 13. Product Picture of Cervical Cancer Screening

Figure 14. Product Picture of Vaginal Cancer Screening

Figure 15. Product Picture of Other

Figure 16. Global HPV Testing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 17. Global HPV Testing Sales Value Market Share by Application, 2023 & 2030

Figure 18. North America HPV Testing Sales Value (2019-2030) & (US$ Million)

Figure 19. North America HPV Testing Sales Value by Country (%), 2023 VS 2030

Figure 20. Europe HPV Testing Sales Value (2019-2030) & (US$ Million)

Figure 21. Europe HPV Testing Sales Value by Country (%), 2023 VS 2030

Figure 22. Asia Pacific HPV Testing Sales Value (2019-2030) & (US$ Million)

Figure 23. Asia Pacific HPV Testing Sales Value by Country (%), 2023 VS 2030

Figure 24. South America HPV Testing Sales Value (2019-2030) & (US$ Million)

Figure 25. South America HPV Testing Sales Value by Country (%), 2023 VS 2030

Figure 26. Middle East & Africa HPV Testing Sales Value (2019-2030) & (US$ Million)

Figure 27. Middle East & Africa HPV Testing Sales Value by Country (%), 2023 VS 2030

Figure 28. Key Countries/Regions HPV Testing Sales Value (%), (2019-2030)

Figure 29. United States HPV Testing Sales Value, (2019-2030) & (US$ Million)

Figure 30. United States HPV Testing Sales Value by Type (%), 2023 VS 2030

Figure 31. United States HPV Testing Sales Value by Application (%), 2023 VS 2030

Figure 32. Europe HPV Testing Sales Value, (2019-2030) & (US$ Million)

Figure 33. Europe HPV Testing Sales Value by Type (%), 2023 VS 2030

Figure 34. Europe HPV Testing Sales Value by Application (%), 2023 VS 2030

Figure 35. China HPV Testing Sales Value, (2019-2030) & (US$ Million)

Figure 36. China HPV Testing Sales Value by Type (%), 2023 VS 2030

Figure 37. China HPV Testing Sales Value by Application (%), 2023 VS 2030

Figure 38. Japan HPV Testing Sales Value, (2019-2030) & (US$ Million)

Figure 39. Japan HPV Testing Sales Value by Type (%), 2023 VS 2030

Figure 40. Japan HPV Testing Sales Value by Application (%), 2023 VS 2030

Figure 41. South Korea HPV Testing Sales Value, (2019-2030) & (US$ Million)

Figure 42. South Korea HPV Testing Sales Value by Type (%), 2023 VS 2030

Figure 43. South Korea HPV Testing Sales Value by Application (%), 2023 VS 2030

Figure 44. Southeast Asia HPV Testing Sales Value, (2019-2030) & (US$ Million)

Figure 45. Southeast Asia HPV Testing Sales Value by Type (%), 2023 VS 2030

Figure 46. Southeast Asia HPV Testing Sales Value by Application (%), 2023 VS 2030

Figure 47. India HPV Testing Sales Value, (2019-2030) & (US$ Million)

Figure 48. India HPV Testing Sales Value by Type (%), 2023 VS 2030

Figure 49. India HPV Testing Sales Value by Application (%), 2023 VS 2030

Figure 50. HPV Testing Industrial Chain

Figure 51. HPV Testing Manufacturing Cost Structure

Figure 52. Channels of Distribution (Direct Sales, and Distribution)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions